drugset / Trial / NCT06722664
Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.
Phase 2
Active not recruiting
336 enrolled
Healthgen Biotechnology Corp.
Beijing Friendship Hospital · collab
RandomizedParallel-groupQuadruple-blindDiagnostic
Summary
Study was designed to evaluate efficacy of OsrhCT and Dimethicone emulsion before upper endoscopy on visibility of gastric mucosa. A total of 336 subjects (both male and female) are expected to be enrolled in this trial.
Timeline
- Start
- 2024-12-19
- Primary completion
- 2025-05-15
- Completion
- 2025-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Human Chymotrypsin | Protein / enzyme biologic | 4000 iu | — |
| Subject | Recombinant Human Chymotrypsin | Protein / enzyme biologic | 8000 iu | — |
| Background | Dimethicone emulsion | Unknown | 4 ml | — |